These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8017742)

  • 1. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
    Klinkenberg-Knol EC; Festen HP; Jansen JB; Lamers CB; Nelis F; Snel P; Lückers A; Dekkers CP; Havu N; Meuwissen SG
    Ann Intern Med; 1994 Aug; 121(3):161-7. PubMed ID: 8017742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
    Creutzfeldt W; Lamberts R
    Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.
    Klinkenberg-Knol EC; Nelis F; Dent J; Snel P; Mitchell B; Prichard P; Lloyd D; Havu N; Frame MH; Romàn J; Walan A;
    Gastroenterology; 2000 Apr; 118(4):661-9. PubMed ID: 10734017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.
    Ligumsky M; Lysy J; Siguencia G; Friedlander Y
    J Clin Gastroenterol; 2001 Jul; 33(1):32-5. PubMed ID: 11418787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
    Koop H; Arnold R
    Dig Dis Sci; 1991 May; 36(5):552-7. PubMed ID: 1673654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output.
    Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Meuwissen SG
    Scand J Gastroenterol; 1990 Nov; 25(11):1144-50. PubMed ID: 1980377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.
    Jansen JB; Klinkenberg-Knol EC; Meuwissen SG; De Bruijne JW; Festen HP; Snel P; Lückers AE; Biemond I; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):621-8. PubMed ID: 2199288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs and controls.
    Diebold MD; Richardson S; Duchateau A; Bigard MA; Colin R; Cortot A; Fauchère JL; Zeitoun P
    Dig Dis Sci; 1998 Aug; 43(8):1629-35. PubMed ID: 9724142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
    Hallerbäck B; Unge P; Carling L; Edwin B; Glise H; Havu N; Lyrenäs E; Lundberg K
    Gastroenterology; 1994 Nov; 107(5):1305-11. PubMed ID: 7926494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
    Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
    J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole in H2 receptor antagonist-resistant reflux esophagitis.
    Marciano-D'Amore DA; Paterson WG; Da Costa LR; Beck IT
    J Clin Gastroenterol; 1990 Dec; 12(6):616-20. PubMed ID: 1979984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole.
    Creutzfeldt W; Lamberts R; Stöckmann F; Brunner G
    Scand J Gastroenterol Suppl; 1989; 166():122-8; discussion 138-9. PubMed ID: 2513642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of omeprazole in healing and prevention of reflux disease.
    Klinkenberg-Knol EC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
    Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
    Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.